Rigel Pharmaceuticals RIGL Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's prepaid & other current?
- Rigel Pharmaceuticals (RIGL) reported prepaid & other current of $25.75M in Q1 2026.
- How has Rigel Pharmaceuticals's prepaid & other current changed year-over-year?
- Rigel Pharmaceuticals's prepaid & other current increased by 10.7% year-over-year, from $23.26M to $25.75M.
- What is the long-term trend for Rigel Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's prepaid & other current has grown at a 9.3% compound annual growth rate (CAGR), from $14.05M to $21.94M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.